Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study

INTRODUCTION: Hepatocellular carcinoma (HCC) is a serious complication of chronic liver disease. Lenvatinib is an oral multikinase inhibitor registered to treat advanced HCC. This study evaluates the real-world experience with lenvatinib in Australia. METHODS: We conducted a retrospective cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Patwala, Kurvi, Prince, David Stephen, Celermajer, Yael, Alam, Waafiqa, Paul, Eldho, Strasser, Simone Irene, McCaughan, Geoffrey William, Gow, Paul, Sood, Siddharth, Murphy, Elise, Roberts, Stuart, Freeman, Elliot, Stratton, Elizabeth, Davison, Scott Anthony, Levy, Miriam Tania, Clark-Dickson, McCawley, Nguyen, Vi, Bell, Sally, Nicoll, Amanda, Bloom, Ashley, Lee, Alice Unah, Ryan, Marno, Howell, Jessica, Valaydon, Zina, Mack, Alexandra, Liu, Ken, Dev, Anouk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525325/
https://www.ncbi.nlm.nih.gov/pubmed/36006547
http://dx.doi.org/10.1007/s12072-022-10398-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525325/
https://www.ncbi.nlm.nih.gov/pubmed/36006547
http://dx.doi.org/10.1007/s12072-022-10398-5

Ejemplares similares